Introduction
Anaplastic large cell lymphoma (ALCL) is a T/Null cell neoplasm characterised by the expression of a hybrid protein comprising an N-terminal partner protein fused to the cytoplasmic portion of the ALK (Anaplastic Lymphoma Kinase) tyrosine kinase. The full-length ALK protein belongs to the family of receptor tyrosine kinases and is highly conserved across species 1 . In approximately 80% of ALK-positive lymphomas, the hybrid kinase is the NPM-ALK fusion protein which is encoded by the NPM (nucleophosmin)-ALK fusion gene resulting from the , STAT-3 12, 13 and STAT-5 14 as well as Src-kinases 15 .
Several model systems have been established to study the oncogenic mechanisms employed by ALK fusion proteins, including transgenic mice, which develop lymphoma when NPM-ALK expression is directed to lymphocytes 16, 17 , and cultured cells which acquire transformed properties when they express ALK fusion protein 10, 18 and for a review 1 . A recent analysis of NPM-ALKassociated proteins in the t(2;5)-positive line Karpas 299 led to the identification of a number of proteins and highlighted to the complexity of the molecular mechanisms underlying NPM-ALK oncogenicity 19 .
In this study, we characterized AUF1/hnRNPD as a new partner of NPM-ALK. AUF1 belongs to the family of AU-binding proteins (AU-BPs) which regulate the cellular half-lives of many mRNAs by directly interacting with an A+U-rich element (ARE) located in their 3' untranslated region [20] [21] [22] . Although AREs are found in mRNAs coding for a wide range of proteins 23 , many ARE-containing mRNAs are transcribed from early response genes (ERGs) encoding proto- ALK can phosphorylate AUF1 in vitro and AUF1 is found in a hyperphosphorylated state in NPM-ALK-expressing NIH3T3 cells. The stability of several ARE-containing mRNAs known to be AUF1 targets is increased in NPM-ALK-expressing NIH3T3 cells compared to controls and contributes to the enhanced cell survival observed after transcriptional arrest. Altering mRNA stability via hyperphosphorylation of AUF1 could represent an important aspect of NPM-ALK tumorigenicity.
Methods

Cell culture, transfection and immunocytochemistry
SU-DHL1 (a gift from M. Cleary, Stanford University, USA), KARPAS 299 29 , COST and FEPD cells were grown in Iscove's modified Dulbecco's medium (IMDM from Invitrogen). X-ALK stably transfected NIH3T3 cells are described in 18 . For Actinomycin D pulse chase experiments, 2 µg Actinomycin D (Sigma) were added per ml of cell culture medium and RNA was extracted using Trizol (Invitrogen).
For IF analysis, NIH3T3 cells were seeded on cover glasses (10 4 cells/ml), cultured overnight, fixed, permeabilized and stained as described in 31, 32 . confocal microscope equipped with helium-neon lasers and appropriate filter combinations.
ALCL-derived cells were pelleted, fixed, permeabilized and stained as described for NIH3T3 cells.
Immunoprecipitation and Western blot analysis
For 1D gel analysis, total protein extracts were prepared from NIH3T3 or ALCL cell lines as previously described 15 ; nitrocellulose membranes (Hybond-ECL, Amersham) were probed with anti-AUF1 (monoclonal 5B9, generous gift from G. Dreyfuss, or polyclonal 1875, generous gift from G. Brewer and Upstate), anti-HuR (monoclonal 3A2, a generous gift of I. Gallouzi), anti-ALK1 or anti-ALKc (a generous gift of Dr. Falini), or anti-phospho-tyrosine (PY-Plus Zymed Laboratories). As a secondary antibody, a goat-anti-mouse peroxidase-conjugated IgG (GAM PO,
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For immunoprecipitation, cells were lysed in lysis buffer (10mM Tris-HCl pH7.5, 150 mM NaCl, 1 mM EDTA, 4mM EGTA, 1mM orthovanadate (Na3VO4), 10 mM benzamidine, 1% NP-40, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 10 µg/ml aprotinin and 1 PMSF) and kept at 4°C under rotation for 30 min. Lysates were precleared and, after centrifugation, were incubated at 4°C for 2 hours with monoclonal anti-ALK1, anti-PY or anti-AUF1 antibody coupled to protein ASepharose beads (Amersham). After centrifugation, immuno-complexes were washed three times with the lysis buffer and boiled in sample buffer. For 2D Western blot analysis of AUF1
immunoprecipitates, 700 µg of proteins extracted from pcDNA3-or NPM-ALK-transfected cells were incubated overnight at 4°C with monoclonal AUF1 antibody; washed immunoprecipitates were solubilized, loaded onto immobiline strips (pH 3-10, 11 cm; Amersham), focused with IPFGPHOR Isoelectric focusing system and subjected simultaneously to SDS-PAGE with a Multiphor II electrophoresis unit according to the manufacturer's instructions (Amersham).
Proteomic and mass spectrometry analyses
Anti-ALK immunoprecipitates from SU-DHL1 and FEPD ALCL cells were separated on an SDS-PAGE gel and visualized using colloidal blue staining. Excised bands were digested with modified trypsin (Promega). Peptide mass fingerprinting was carried out by using a MALDI-TOF mass spectrometer (Applied Biosystems, Voyager DE STR, Framinghanm, MA, USA) on each protein band. Unknown proteins were identified using the database fitting program MS-Fit (Protein Prospector, (http://prospector.ucsf.edu). Mass accuracy of 10 ppm was obtained with internal calibration using auto-digestion peaks of trypsin (M+H+, 842.51, 2211.10, and 2283.18).
RNase protection assay and riboprobes
The mCYC-1 mouse cyclin multi-probe template set (BD Pharmingen) was used to synthesize high-specific-activity α- 
Results
AUF1 is a partner of ALK
To gain insight into the molecular mechanisms underlying ALK-induced oncogenesis in ALCLs, a mass spectrometric analysis of ALK-containing immunoprecipitates was undertaken using the NPM-ALK-positive SU-DHL1 line 24 and the ALK-negative FEPD line 25 as a control. , which were the most abundant isoforms in the IP, were resolved into several spots corresponding to charge differences. Several more negatively charged variants of AUF1 were observed in NPM-ALK-positive cells (arrow in Figure 3 ). These and the other spots were recognized by the anti-P-Tyr. antibody (αpY). These results indicate that AUF1 is phosphorylated on tyrosine residues under basal condition and that NPM-ALK expression leads to addition of phosphate groups, either to tyrosine or threonine/serine residues (see discussion). All together, our results indicate that NPM-ALK is complexed with AUF1 and enhances its phosphorylation.
AUF1 and NPM-ALK colocalise in cytoplasmic foci
To further investigate the association of AUF1 and NPM-ALK, we analysed their cellular localisation by immunofluorescence. Apart from their expected high level of expression in the nucleus (NPM-ALK being found in the nucleoli while AUF1 is excluded from this compartment), both proteins were found concentrated in large foci (0. were reminiscent of processing bodies (P-bodies) that are the sites of mRNA degradation in yeast 30 and mammals 31, 32 . To ascertain whether NPM-ALK and AUF1 colocalised within these structures, we used Dcp1a, which is an established marker of P-bodies 30 . The results of double IF labelling using anti-NPM-ALK and anti-hDCP1a antibodies showed both proteins to be present in discrete foci (Figure 4d , ALK and e, hDcp1), which, as shown by the merged view, were essentially non overlapping in NPM-ALK-expressing NIH3T3 (4f and right insert) and ALCL- Figure 5C and 5D). We also observed increased half-life of cyclin A2, B1, and D3 mRNA in ALK-expressing cells ( Figure   5D and data not shown for an independently performed experiment).
Delayed cell death in NPM-ALK-expressing cells
Analysis of cyclin mRNA half-lives required a longer period of analysis. Strikingly, while more than 50% of control (pcDNA3 or NPM-ALK Dead) cells were dead after 12h of ActD treatment, more than 80% of NPM-ALK-expressing NIH3T3 cells remained healthy at this time and almost a third had survived at 36h, as determined by nuclear DAPI staining ( Figure 6A ).
Furthermore, in ALCL-derived cells, approximately 50% of FEPD cells were dead 2h after treatment, while cell death in Karpas, SU-DHL1 and COST occurred 3 to 5h later, Karpas cells being the least resistant ( Figure 6B ). Taken together, these data strongly suggest that NPM-ALK acts at a post-trancriptional level by enhancing mRNA stability, which in turn protects cells from death.
Discussion
Numerous studies have been aimed at understanding how ARE-binding proteins assemble on a given ARE and how they interact with auxiliary proteins to form various complexes which We first describe the association between AUF1 and ALK in various cell types, including human cell lines derived from (2;5)(p23;q35) ALCLs or murine NIH3T3 cell lines expressing different X-ALK fusion proteins. We show that AUF1 and ALK association requires the ALK portion of the X-ALK fusion protein. Interestingly, colocalisation of these proteins was observed in large cytoplasmic granules which, although resembling P-bodies, did not contain Dcp1, a hallmark of these structures 31, 54 . Formation of these cytoplasmic foci, which have recently been described in Karpas 299 cells 55 , requires ALK kinase activity, since they were not observed in NIH3T3 cells expressing the kinase-dead NPM-ALK (K210R) mutant. The nature and the components of these structures are currently under characterization.
In the absence of appropriate antibodies, it is difficult to ascertain which AUF1 isoform(s) is present in the cytoplasmic foci. However, mass spectrometric analysis and IP data clearly indicate that p45 AUF1 is reproducibly found associated with NPM-ALK in murine and human cell lines. The other isoforms are also present but their amount is variable from cell to cell. For instance, although the p45 AUF1 and p40 AUF1 isoforms are expressed at similar level in Karpas and SU-DHL1, more p40 AUF1 is associated with NPM-ALK in SU-DHL1. As AUF1 isoforms are able to oligomerize 56, 57 , these differences may be linked to the composition of the oligomers formed.
Association of NPM-ALK with AUF1 isoforms resulted in their increased phosphorylation on tyrosine residues. This was observed in NIH3T3 cells as well as in ALCL-derived cell lines, where
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From more negatively charged forms were specifically found in NPM-ALK-expressing cells. These variants were recognized by the anti-phosphotyrosine antibody, suggesting that they contained additional phosphates on tyrosine residues. This hypothesis is strengthened by the observation that ALK can phosphorylate the four isoforms in vitro (not shown). However, we cannot exclude the possibility that these phosphorylated forms have also acquired additional phosphates on serine or threonine residues, as recently reported 37, 58 . Further experiments are needed to map the residues phosphorylated following constitutive activation of NPM-ALK.
The . Thus, the ability of NPM-ALK to act both at the transcriptional and post-transcriptional levels by increasing the half-life of short-lived mRNAs contributes to cell survival, enhanced proliferation and tumorigenesis.
In conclusion, the present work shows for the first time that AUF1 interacts with and is posttranslationally modified by an oncogenic tyrosine kinase. The change in the phosphorylation state of AUF1 and its concentration in NPM-ALK-containing cytoplasmic granules are correlated with an increase in the level of expression of several ARE-containing mRNAs. We thus postulate that modification of AUF1 activity or availability through ALK recruitment leads to a decrease in ARE-directed mRNA turnover and contributes to enhanced cellular proliferation and oncogenicity.
This novel mechanism, together with well characterized anti-apoptotic signalling pathways activated by NPM-ALK 66 , may contribute to malignancy.
Further studies aimed at analyzing precisely the interaction between AUF1 and ALK and the amino acid residues phosphorylated may lead to new therapeutic approaches for the treatment of ALK-expressing lymphomas. Moreover, if the partnership between AUF1 and ALK turns out to be applicable to other AU-BPs and kinases, the study of impaired mRNA stability could constitute an important breakthrough in understanding the molecular pathogenesis of hematopoetic malignancies.
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